http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2632105-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f442ffd1ff02fe7cab9ddf670534e95 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-739 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-739 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate | 2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754ec7dc5278f8b3fe19b186ebfc4564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa40ff5be779ccd5e6175b949042abed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d679d0e8376de0a779112e10c4bd848e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa858d526e962ede020a5ab2567e106d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4610691097629b534517b89c4b2e04ba |
| publicationDate | 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2632105-C1 |
| titleOfInvention | Method for complex conservative treatment of uterine myoma |
| abstract | FIELD: medicine. n SUBSTANCE: complex conservative treatment of uterine myoma is carried out in two stages: prehormonal preparation and hormonal drugs are prescribed. At the first stage, 1 month before hormone therapy appointment, on the third day of the menstrual cycle, an immunotherapy course with Pyrogenal is prescribed at a dose of 25 mcg intramuscularly every 48 hours with a sequential increase in the dose by 25 mcg until the body temperature is raised to at least 38°C, but not more than the maximum dose of 150 mcg of Pyrogenal. From the moment of temperature increase, the combined antibacterial, antiprotozoal, antimycotic and antiviral therapy starts in combination with EHF-therapy - daily for 30 minutes per sternum area at the level of the 2nd rib, for 10 days. In the next cycle, hormone therapy is prescribed for 3 months by any of the known drugs. n EFFECT: use of the invention allows to increase the efficacy of conservative treatment of uterine myoma, reliably prevent the complications of hormone therapy and the relapse of tumor growth. n 5 tbl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2730926-C1 |
| priorityDate | 2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.